Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Illustration of the Cis C797S and Trans C797S mutation and their ...
Next-generation EGFR tyrosine kinase inhibitors to overcome C797S ...
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation ...
EGFR C797S mutation mediates resistance to third-generation inhibitors ...
Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated ...
Allelic context and frequencies of EGFR C797S mutation and EGFR T790M ...
C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans ...
Fourth generation allosteric C797S EGFR inhibitors (Y shaped ...
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to ...
The Allelic Context of the C797S Mutation Acquired upon Treatment with ...
(PDF) EGFR C797S mutation mediates resistance to third-generation ...
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced ...
The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor ...
EGFR T790M C797S Reference Standard, mutation | GeneCopoeia™
High Incidence of C797S Mutation in Patients With Long Treatment ...
EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S ...
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung ...
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to ...
Full article: Fourth-generation EGFR-TKI to overcome C797S mutation ...
EGFR C797S and KRAS Alterations Confer Acquired Resistance to ...
Acquired EGFR C797S mediates resistance to AZD9291 in advanced non ...
EGFR C797S EGFR T790M and EGFR sensitizing mutations in nonsmall cell ...
Acquired C797S Mutation upon Treatment with a T790M-Specific Third ...
Re-emerging C797S In Trans and Rechallenge of Osimertinib With ...
Frequency of T790M loss and C797S acquisition among different EGFR ...
能够克服 EGFR 耐药突变 C797S 和 EGFR/ALK 共突变的候选药物 DA-0157 的发现和临床前评估,European ...
Characterization of EGFR T790M, L792F, and C797S Mutations as ...
Insights into fourth generation selective inhibitors of (C797S) EGFR ...
EGFR L858R-T790M-C797S/NCI-H1975_药靶模型_南京科佰生物科技有限公司
EGFR T790M/C797S/L858R突变：分子机制与临床转化全景 - 知乎
EGFR-Targeted Therapy: A New Beginning - ILCN.org (ILCN/WCLC)
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating ...
NCI-H1975-EGFR-T790M-C797S-L858R Cell Line - Kyinno Bio
Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del ...
Growth Suppression in Lung Cancer Cells Harboring EGFR-C797S Mutation ...
Frontiers | Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant ...
EGFR Del19-T790M-C797S/PC14_药靶模型_南京科佰生物科技有限公司
Figure 1 from Integrated Omics Analysis of Non-Small-Cell Lung Cancer ...
Design and synthesis of novel EGFR kinase inhibitors for the treatment ...
EGFR[T790M/C797S] - Tyrosine Kinase - ICE Bioscience - Protein platform
Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations ...
EGFR[C797S] - Tyrosine Kinase - ICE Bioscience - Protein platform
EGFR (C797S), Active recombinant | Sigma-Aldrich
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective ...
EGFR d746-750/C797S Recombinant Human Active Protein Kinase | EGFR d746 ...
EGFR L858R-T790M-C797S/BaF3_药靶模型_南京科佰生物科技有限公司
Method and probe for detecting cis-trans mutation configurations of ...
全新第四代EGFR抑制劑將入臨床，有望破解肺癌C797S耐藥突變 - 每日頭條
EGFR[T790M/C797S/L858R] - Tyrosine Kinase - ICE Bioscience - Protein ...
EGFR 19del/T790M/C797S顺式突变肺腺癌，成功获益吉非替尼联合奥希替尼-MedSci.cn
EV-0012 pCMV-EGFR (C797S) | Signosis
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer ...
(PDF) Concurrent Small-Cell Transformation and Emergence of Trans-C797S ...
